Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathlyn Santos

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Gene Therapy|June 22, 2006
Amplicons as vaccine vectorsKathlyn Santos, Cindy M P Duke, Stephen Dewhurst
Journal of Virology|June 14, 2003
Murine cytomegalovirus abortively infects human dendritic cells, leading to expression and presentation of virally vectored genesXiuqing Wang, Martin Messerle, Ramil Sapinoro, et al.
Journal of Virology|February 1, 2005
Human dendritic cells transduced with herpes simplex virus amplicons encoding human immunodeficiency virus type 1 (HIV-1) gp120 elicit adaptive immune responses from human cells engrafted into NOD/SCID mice and confer partial protection against HIV-1 challengeSanthi Gorantla, Kathlyn Santos, Vakara Meyer, et al.
Journal of Virological Methods|July 4, 2007
Infectivity of herpes simplex virus type-1 (HSV-1) amplicon vectors in dendritic cells is determined by the helper virus strain used for packagingKathlyn Santos, Christine M Sanfilippo, Wade C Narrow, et al.
Vaccine|December 6, 2006
Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 GagKathlyn Santos, Cindy M P Duke, Sol M Rodriguez-Colon, et al.
Human Gene Therapy|February 15, 2007
Spatial and temporal expression of herpes simplex virus type 1 amplicon-encoded genes: implications for their use as immunization vectorsKathlyn Santos, David A L Simon, Erin Conway, et al.
Journal of Virology|October 5, 2007
Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infectionMelody G Duvall, Karin Loré, Hetty Blaak, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Gene Therapy|June 22, 2006
Amplicons as vaccine vectorsKathlyn Santos, Cindy M P Duke, Stephen Dewhurst
Journal of Virology|June 14, 2003
Murine cytomegalovirus abortively infects human dendritic cells, leading to expression and presentation of virally vectored genesXiuqing Wang, Martin Messerle, Ramil Sapinoro, et al.
Journal of Virology|February 1, 2005
Human dendritic cells transduced with herpes simplex virus amplicons encoding human immunodeficiency virus type 1 (HIV-1) gp120 elicit adaptive immune responses from human cells engrafted into NOD/SCID mice and confer partial protection against HIV-1 challengeSanthi Gorantla, Kathlyn Santos, Vakara Meyer, et al.
Journal of Virological Methods|July 4, 2007
Infectivity of herpes simplex virus type-1 (HSV-1) amplicon vectors in dendritic cells is determined by the helper virus strain used for packagingKathlyn Santos, Christine M Sanfilippo, Wade C Narrow, et al.
Vaccine|December 6, 2006
Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 GagKathlyn Santos, Cindy M P Duke, Sol M Rodriguez-Colon, et al.
Human Gene Therapy|February 15, 2007
Spatial and temporal expression of herpes simplex virus type 1 amplicon-encoded genes: implications for their use as immunization vectorsKathlyn Santos, David A L Simon, Erin Conway, et al.
Journal of Virology|October 5, 2007
Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infectionMelody G Duvall, Karin Loré, Hetty Blaak, et al.
Pageof 1